United States · FDA National Drug Code directory
Pyridostigmine Bromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559
- Product NDC
- 0115-2134
- Form
- TABLET
- Composition / generic term
- PYRIDOSTIGMINE BROMIDE
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220808
- Source listing expiry
- 20261231
Source-listed ingredients
- PYRIDOSTIGMINE BROMIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 21 TABLET in 1 BOTTLE (0115-2134-01) · 0115-2134-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →